ICH plan to reduce rat carcinogenicity studies moves into new phase
This article was originally published in Scrip
Executive Summary
International plans to reduce the need for the two-year rodent carcinogenicity test, and thereby possibly reduce drug development timelines and increase speed to market, are among the issues to be discussed at the International Conference on Harmonization (ICH) meeting next month in Osaka, Japan.